» Articles » PMID: 35573655

Barriers and Facilitators for Smoking Cessation in Chinese Smokers with Chronic Obstructive Pulmonary Disease: A Qualitative Study

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Smoking cessation is recommended as a key intervention for chronic obstructive pulmonary disease (COPD) smokers. However, in China, few COPD smokers quit successfully. The aim of this study was to explore in depth the barriers and facilitators for smoking cessation among smokers with COPD in China.

Methods: A purposive sample of 32 hospitalized smokers with COPD were included, 17 ex-smokers and 15 current smokers, participated in the semi-structured interviews. Interviews were analyzed thematically and using a deductive approach guided by Capability, Opportunity, Motivation-Behavior (COM-B) framework.

Results: Three inter-related themes were generated: smokers' motivation was a prerequisite for quitting, maintaining capability to quit smoking, and opportunities that facilitated smokers to quit. Motivation to quit for most participants was activated by COPD-related symptoms, although they had a limited knowledge of COPD. Physical benefits from quitting and strong willpower were facilitators for maintaining quitting, while exposure to smoking environment and strong addiction to nicotine were frequent reasons for relapse. Most ex-smokers quit smoking by their own willpower rather than professionally delivered smoking cessation interventions. Smokers' attitudes toward these interventions depended on their effectiveness and convenience. Very few participants had experienced pharmacotherapy or behavioral support from physicians. However, interviewees preferred auricular acupressure to pharmacotherapy.

Conclusion: Motivation to quit among smokers with COPD was usually initiated by COPD-related symptoms. Physical benefits observed by quitting and strong willpower facilitated smoking cessation, while exposure to smoking environment and strong addiction to nicotine led to relapse. COPD smokers in China preferred auricular acupressure to pharmacotherapy.

Citing Articles

A Qualitative Study on Illness Perception and Coping Behaviors Among Patients with Chronic Obstructive Pulmonary Disease: Implications for Intervention.

Huang L, Tan C, Chen X, Jiang Y, Zhou Y, Zhao H Int J Chron Obstruct Pulmon Dis. 2024; 19:2467-2479.

PMID: 39583958 PMC: 11584336. DOI: 10.2147/COPD.S473790.


Efficacy of an individual-tailored smoking cessation intervention APP among Chinese smokers: study protocol for a randomized controlled trial.

Xie X, Liang L, Nan Y, Zhang L, Xiao L BMC Public Health. 2024; 24(1):65.

PMID: 38166920 PMC: 10763077. DOI: 10.1186/s12889-023-16496-9.


A COM-B analysis of facilitators of and barriers to smoking cessation among Chinese smokers: A qualitative study.

Xie X, Nan Y, Lin B, Chen T, Zhang L, Xiao L Tob Induc Dis. 2023; 21:152.

PMID: 38026498 PMC: 10652708. DOI: 10.18332/tid/174128.


Efficacy of WeChat-based online smoking cessation intervention ('WeChat WeQuit') in China: a randomised controlled trial.

Tang J, Yang J, Liu Y, Liu X, Li L, Sun Y EClinicalMedicine. 2023; 60:102009.

PMID: 37251625 PMC: 10209122. DOI: 10.1016/j.eclinm.2023.102009.


Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis.

Shang X, Guo K, E F, Deng X, Wang Y, Wang Z Front Pharmacol. 2022; 13:1012433.

PMID: 36353488 PMC: 9638092. DOI: 10.3389/fphar.2022.1012433.

References
1.
Webb J, Peerbux S, Smittenaar P, Siddiqui S, Sherwani Y, Ahmed M . Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial. JMIR Ment Health. 2020; 7(10):e22833. PMC: 7576529. DOI: 10.2196/22833. View

2.
Wang J, Li C, Jia C, Liu Y, Liu J, Yan X . Smoking, smoking cessation and tobacco control in rural China: a qualitative study in Shandong Province. BMC Public Health. 2014; 14:916. PMC: 4169812. DOI: 10.1186/1471-2458-14-916. View

3.
Shields P, Herbst R, Arenberg D, Benowitz N, Bierut L, Luckart J . Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(11):1430-1468. DOI: 10.6004/jnccn.2016.0152. View

4.
Hammond D, McDonald P, Fong G, Borland R . Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction. 2004; 99(8):1042-8. DOI: 10.1111/j.1360-0443.2004.00754.x. View

5.
Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E . Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2016; 5(2):020415. PMC: 4693508. DOI: 10.7189/jogh.05.020415. View